Annual Net Income
-$51.21 M
-$9.38 M-22.44%
31 December 2023
Summary:
Aptose Biosciences annual net profit is currently -$51.21 million, with the most recent change of -$9.38 million (-22.44%) on 31 December 2023. During the last 3 years, it has risen by +$4.03 million (+7.30%). APTO annual net income is now -1113.50% below its all-time high of $5.05 million, reached on 31 May 2010.APTO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$6.95 M
+$299.00 K+4.12%
30 September 2024
Summary:
Aptose Biosciences quarterly net profit is currently -$6.95 million, with the most recent change of +$299.00 thousand (+4.12%) on 30 September 2024. Over the past year, it has increased by +$4.49 million (+39.26%). APTO quarterly net income is now -178.03% below its all-time high of $8.91 million, reached on 31 August 2009.APTO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$35.80 M
+$4.49 M+11.15%
30 September 2024
Summary:
Aptose Biosciences TTM net profit is currently -$35.80 million, with the most recent change of +$4.49 million (+11.15%) on 30 September 2024. Over the past year, it has increased by +$13.45 million (+27.31%). APTO TTM net income is now -864.01% below its all-time high of $4.69 million, reached on 31 May 2010.APTO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.4% | +39.3% | +27.3% |
| 3 y3 years | +7.3% | +38.6% | +35.8% |
| 5 y5 years | -77.4% | -1.6% | -44.2% |
APTO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -22.4% | +21.6% | at high | +71.4% | at high | +45.2% |
| 5 y | 5 years | -94.9% | +21.6% | -1.6% | +71.4% | -44.2% | +45.2% |
| alltime | all time | -1113.5% | +21.6% | -178.0% | +71.4% | -864.0% | +45.2% |
Aptose Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.95 M(-4.1%) | -$35.80 M(-11.2%) |
| June 2024 | - | -$7.25 M(-24.8%) | -$40.29 M(-14.6%) |
| Mar 2024 | - | -$9.64 M(-19.4%) | -$47.17 M(-7.9%) |
| Dec 2023 | -$51.21 M(+22.4%) | -$11.96 M(+4.4%) | -$51.21 M(+4.0%) |
| Sept 2023 | - | -$11.45 M(-19.0%) | -$49.25 M(+3.5%) |
| June 2023 | - | -$14.13 M(+3.3%) | -$47.58 M(+8.1%) |
| Mar 2023 | - | -$13.68 M(+36.8%) | -$44.02 M(+5.2%) |
| Dec 2022 | -$41.82 M(-36.0%) | -$10.00 M(+2.3%) | -$41.82 M(-25.5%) |
| Sept 2022 | - | -$9.78 M(-7.5%) | -$56.15 M(-2.7%) |
| June 2022 | - | -$10.56 M(-8.0%) | -$57.70 M(-4.8%) |
| Mar 2022 | - | -$11.48 M(-52.8%) | -$60.61 M(-7.3%) |
| Dec 2021 | -$65.35 M(+18.3%) | -$24.32 M(+114.6%) | -$65.35 M(+17.2%) |
| Sept 2021 | - | -$11.33 M(-15.9%) | -$55.74 M(-3.3%) |
| June 2021 | - | -$13.47 M(-17.0%) | -$57.66 M(-3.8%) |
| Mar 2021 | - | -$16.23 M(+10.3%) | -$59.94 M(+8.5%) |
| Dec 2020 | -$55.24 M(+110.2%) | -$14.71 M(+11.0%) | -$55.24 M(+14.5%) |
| Sept 2020 | - | -$13.25 M(-15.9%) | -$48.23 M(+15.3%) |
| June 2020 | - | -$15.75 M(+36.6%) | -$41.83 M(+29.5%) |
| Mar 2020 | - | -$11.53 M(+49.5%) | -$32.30 M(+22.9%) |
| Dec 2019 | -$26.28 M(-9.0%) | -$7.71 M(+12.6%) | -$26.28 M(+5.8%) |
| Sept 2019 | - | -$6.84 M(+10.1%) | -$24.83 M(+5.6%) |
| June 2019 | - | -$6.22 M(+12.9%) | -$23.52 M(-14.7%) |
| Mar 2019 | - | -$5.51 M(-12.1%) | -$27.56 M(-4.5%) |
| Dec 2018 | -$28.87 M(+147.9%) | -$6.26 M(+13.2%) | -$28.87 M(+11.6%) |
| Sept 2018 | - | -$5.53 M(-46.1%) | -$25.88 M(+12.6%) |
| June 2018 | - | -$10.26 M(+50.6%) | -$22.99 M(+51.6%) |
| Mar 2018 | - | -$6.81 M(+108.4%) | -$15.16 M(+30.2%) |
| Dec 2017 | -$11.64 M(-18.2%) | -$3.27 M(+23.9%) | -$11.64 M(+1.9%) |
| Sept 2017 | - | -$2.64 M(+8.2%) | -$11.43 M(-3.5%) |
| June 2017 | - | -$2.44 M(-25.9%) | -$11.85 M(-13.8%) |
| Mar 2017 | - | -$3.29 M(+7.6%) | -$13.74 M(-4.3%) |
| Dec 2016 | -$14.24 M(+21.6%) | -$3.06 M(+0.1%) | -$14.36 M(-6.9%) |
| Sept 2016 | - | -$3.06 M(-29.6%) | -$15.42 M(+4.2%) |
| June 2016 | - | -$4.34 M(+11.0%) | -$14.79 M(+12.4%) |
| Mar 2016 | - | -$3.91 M(-5.1%) | -$13.16 M(+9.0%) |
| Dec 2015 | -$11.71 M(+74.9%) | -$4.12 M(+69.5%) | -$12.07 M(+51.8%) |
| Sept 2015 | - | -$2.43 M(-10.4%) | -$7.96 M(+44.0%) |
| June 2015 | - | -$2.71 M(-3.7%) | -$5.53 M(-17.6%) |
| Mar 2015 | - | -$2.82 M(-27.6%) | -$6.71 M(-31.3%) |
| Dec 2014 | -$6.69 M(-31.2%) | - | - |
| May 2014 | -$9.73 M(+80.1%) | -$3.89 M(+77.9%) | -$9.76 M(+37.1%) |
| Feb 2014 | - | -$2.19 M(-17.0%) | -$7.12 M(+13.5%) |
| Nov 2013 | - | -$2.64 M(+152.3%) | -$6.27 M(+19.2%) |
| Aug 2013 | - | -$1.04 M(-16.4%) | -$5.26 M(-4.1%) |
| May 2013 | -$5.40 M(+20.6%) | -$1.25 M(-6.7%) | -$5.48 M(+7.7%) |
| Feb 2013 | - | -$1.34 M(-17.5%) | -$5.09 M(+6.5%) |
| Nov 2012 | - | -$1.62 M(+27.7%) | -$4.78 M(+4.7%) |
| Aug 2012 | - | -$1.27 M(+48.6%) | -$4.57 M(+2.9%) |
| May 2012 | -$4.48 M(-12.4%) | -$855.60 K(-16.8%) | -$4.44 M(-5.4%) |
| Feb 2012 | - | -$1.03 M(-27.1%) | -$4.69 M(-10.5%) |
| Nov 2011 | - | -$1.41 M(+23.3%) | -$5.24 M(+4.3%) |
| Aug 2011 | - | -$1.14 M(+3.2%) | -$5.03 M(+1.1%) |
| May 2011 | -$5.11 M | -$1.11 M(-29.7%) | -$4.97 M(-11.4%) |
| Feb 2011 | - | -$1.58 M(+31.8%) | -$5.61 M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | -$1.20 M(+9.8%) | -$5.32 M(-0.0%) |
| Aug 2010 | - | -$1.09 M(-37.7%) | -$5.32 M(-213.4%) |
| May 2010 | $5.05 M(-162.2%) | -$1.75 M(+37.0%) | $4.69 M(+23.5%) |
| Feb 2010 | - | -$1.28 M(+6.8%) | $3.79 M(+21.3%) |
| Nov 2009 | - | -$1.20 M(-113.4%) | $3.13 M(+25.8%) |
| Aug 2009 | - | $8.91 M(-437.3%) | $2.49 M(-129.2%) |
| May 2009 | -$8.13 M(+27.6%) | -$2.64 M(+35.9%) | -$8.51 M(-10.4%) |
| Feb 2009 | - | -$1.94 M(+5.7%) | -$9.50 M(-17.3%) |
| Nov 2008 | - | -$1.84 M(-11.7%) | -$11.48 M(-7.9%) |
| Aug 2008 | - | -$2.08 M(-42.7%) | -$12.47 M(+88.7%) |
| May 2008 | -$6.37 M(-29.3%) | -$3.63 M(-7.5%) | -$6.61 M(+27.2%) |
| Feb 2008 | - | -$3.93 M(+39.1%) | -$5.19 M(+71.6%) |
| Nov 2007 | - | -$2.82 M(-174.7%) | -$3.03 M(+3.1%) |
| Aug 2007 | - | $3.78 M(-270.1%) | -$2.94 M(-68.2%) |
| May 2007 | -$9.01 M(-44.6%) | -$2.22 M(+26.1%) | -$9.22 M(-9.0%) |
| Feb 2007 | - | -$1.76 M(-35.5%) | -$10.14 M(-15.3%) |
| Nov 2006 | - | -$2.73 M(+9.0%) | -$11.97 M(-12.0%) |
| Aug 2006 | - | -$2.51 M(-20.1%) | -$13.61 M(-14.6%) |
| May 2006 | -$16.27 M(-7.5%) | -$3.14 M(-12.9%) | -$15.94 M(-1.8%) |
| Feb 2006 | - | -$3.60 M(-17.6%) | -$16.23 M(-4.0%) |
| Nov 2005 | - | -$4.37 M(-9.6%) | -$16.91 M(-3.6%) |
| Aug 2005 | - | -$4.83 M(+41.1%) | -$17.54 M(+0.4%) |
| May 2005 | -$17.58 M(-20.9%) | -$3.43 M(-19.8%) | -$17.47 M(-10.6%) |
| Feb 2005 | - | -$4.27 M(-14.6%) | -$19.55 M(-8.6%) |
| Nov 2004 | - | -$5.01 M(+5.3%) | -$21.39 M(+1.8%) |
| Aug 2004 | - | -$4.76 M(-13.6%) | -$21.00 M(-5.2%) |
| May 2004 | -$22.24 M(+83.5%) | -$5.51 M(-9.9%) | -$22.15 M(+6.6%) |
| Feb 2004 | - | -$6.11 M(+32.3%) | -$20.77 M(+20.6%) |
| Nov 2003 | - | -$4.62 M(-21.7%) | -$17.22 M(+13.8%) |
| Aug 2003 | - | -$5.90 M(+42.8%) | -$15.14 M(+27.7%) |
| May 2003 | -$12.12 M(+37.3%) | -$4.13 M(+61.4%) | -$11.85 M(+13.4%) |
| Feb 2003 | - | -$2.56 M(+1.0%) | -$10.45 M(+6.9%) |
| Nov 2002 | - | -$2.54 M(-3.0%) | -$9.77 M(+2.0%) |
| Aug 2002 | - | -$2.62 M(-4.2%) | -$9.58 M(+7.2%) |
| May 2002 | -$8.83 M(-10.8%) | -$2.73 M(+44.5%) | -$8.93 M(-12.3%) |
| Feb 2002 | - | -$1.89 M(-19.3%) | -$10.19 M(+1.1%) |
| Nov 2001 | - | -$2.34 M(+18.7%) | -$10.08 M(-1.3%) |
| Aug 2001 | - | -$1.97 M(-50.5%) | -$10.22 M(+2.5%) |
| May 2001 | -$9.89 M(+72.4%) | -$3.99 M(+123.7%) | -$9.97 M(+6.3%) |
| Feb 2001 | - | -$1.78 M(-28.1%) | -$9.38 M(+7.0%) |
| Nov 2000 | - | -$2.48 M(+44.0%) | -$8.77 M(+25.8%) |
| Aug 2000 | - | -$1.72 M(-49.3%) | -$6.97 M(+21.9%) |
| May 2000 | -$5.74 M(+84.0%) | -$3.40 M(+189.9%) | -$5.71 M(+75.8%) |
| Feb 2000 | - | -$1.17 M(+72.5%) | -$3.25 M(+21.5%) |
| Nov 1999 | - | -$679.10 K(+45.0%) | -$2.68 M(+1.1%) |
| Aug 1999 | - | -$468.40 K(-49.7%) | -$2.65 M(-15.4%) |
| May 1999 | -$3.12 M(-3.3%) | -$932.10 K(+56.2%) | -$3.13 M(+0.8%) |
| Feb 1999 | - | -$596.60 K(-8.4%) | -$3.10 M(-5.4%) |
| Nov 1998 | - | -$651.00 K(-31.4%) | -$3.28 M(-5.5%) |
| Aug 1998 | - | -$949.10 K(+4.5%) | -$3.47 M(+7.1%) |
| May 1998 | -$3.23 M(-7.4%) | -$908.00 K(+17.5%) | -$3.24 M(+38.9%) |
| Feb 1998 | - | -$772.90 K(-8.3%) | -$2.34 M(+49.4%) |
| Nov 1997 | - | -$843.30 K(+17.1%) | -$1.56 M(+117.1%) |
| Aug 1997 | - | -$719.90 K | -$719.90 K |
| May 1997 | -$3.48 M | - | - |
FAQ
- What is Aptose Biosciences annual net profit?
- What is the all time high annual net income for Aptose Biosciences?
- What is Aptose Biosciences annual net income year-on-year change?
- What is Aptose Biosciences quarterly net profit?
- What is the all time high quarterly net income for Aptose Biosciences?
- What is Aptose Biosciences quarterly net income year-on-year change?
- What is Aptose Biosciences TTM net profit?
- What is the all time high TTM net income for Aptose Biosciences?
- What is Aptose Biosciences TTM net income year-on-year change?
What is Aptose Biosciences annual net profit?
The current annual net income of APTO is -$51.21 M
What is the all time high annual net income for Aptose Biosciences?
Aptose Biosciences all-time high annual net profit is $5.05 M
What is Aptose Biosciences annual net income year-on-year change?
Over the past year, APTO annual net profit has changed by -$9.38 M (-22.44%)
What is Aptose Biosciences quarterly net profit?
The current quarterly net income of APTO is -$6.95 M
What is the all time high quarterly net income for Aptose Biosciences?
Aptose Biosciences all-time high quarterly net profit is $8.91 M
What is Aptose Biosciences quarterly net income year-on-year change?
Over the past year, APTO quarterly net profit has changed by +$4.49 M (+39.26%)
What is Aptose Biosciences TTM net profit?
The current TTM net income of APTO is -$35.80 M
What is the all time high TTM net income for Aptose Biosciences?
Aptose Biosciences all-time high TTM net profit is $4.69 M
What is Aptose Biosciences TTM net income year-on-year change?
Over the past year, APTO TTM net profit has changed by +$13.45 M (+27.31%)